MYGN MYRIAD GENETICS INC
P/E
--
Forward P/E
54.05
Price/Sales
0.69
Beta
1.643
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Myriad Genetics Discloses Cybersecurity Incident and Temporary Suspension of Operations
Myriad Genetics reported a cybersecurity incident involving unauthorized access to its IT network, which was detected on November 2, 2026. In response, the...
Myriad Genetics misses third quarter 2026 expectations; divests prenatal unit for $210 million
Myriad Genetics reported third quarter 2026 revenue of $202.7 million, missing the analyst estimate of $215.4 million. The company recorded an adjusted loss...
Myriad Genetics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Myriad Genetics is expected to report Q3 2026 revenue of $215.4 million and an adjusted EPS of $0.05, with the current stock price of $28.45 trading below the...
Myriad Genetics to Sell Prenatal Health Business to Labcorp in $210M Cash Deal
Myriad Genetics, Inc. has entered into a definitive asset purchase agreement to sell its prenatal health business to Laboratory Corporation of America for $210...